Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/307% below fair value
$3.38−0.03 (-0.88%)
Close on Nov 13, 2026Market cap $1.25BP/E 19.9Yield –
Cronos total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Cronos
Cronos has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?